Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AFFYMETRIX (AFFX) -- Ignore unavailable to you. Want to Upgrade?

To: JF Quinnelly who wrote (1537)	12/24/2001 10:27:08 AM
From: Jon Koplik	Read Replies (1) \| Respond to of 1728

Affymetrix and Incyte Genomics Settle All Patent Infringement Litigation PALO ALTO, Calif. and SANTA CLARA, Calif., Dec 21, 2001 /PRNewswire via COMTEX/ -- Incyte Genomics, Inc. (Nasdaq: INCY chart, msgs), the leading genomics information company and Affymetrix, Inc., (Nasdaq: AFFX chart, msgs) the leader in creating breakthrough tools for the genomic revolution, today announced a comprehensive settlement of all existing infringement litigation between the two companies. The first lawsuit involved several of Affymetrix microarray-related patents (U.S. Patent Nos. 5,445,934, 5,744305, 5,800,992, 5,871,928, 6,040,193). The second lawsuit involved Incyte's RNA amplification patents (U.S. Patent Nos. 5,716,785, 5,891,636). The companies have agreed to cross-licenses under their respective intellectual property portfolios. Financial terms were not disclosed. Affymetrix and Incyte also are investigating possible future commercial agreements between the companies Source: Incyte Genomics, Inc.

To: JF Quinnelly who wrote (1537)	1/28/2002 10:08:48 PM
From: Maurice Winn	Read Replies (2) \| Respond to of 1728

Ouch! < Affymetrix Inc. (Nasdaq:AFFX - news) took a hit, along with other biotechnology shares, after consulting group Off Wall Street recommended investors bet shares of the genetic analysis firm will fall. Affymetrix sank $5.87 to $30.93, while the Nasdaq Biotechnology Index (^NBI - news) tumbled 2.73 percent.> dailynews.yahoo.com Good bet. That was a bit of a Goedlian bet [self-reverential and all that]http://www.hyponoesis.org/html/essays/e018.html Google is so smart! Who needs a brain when Google is there to do the thinking? Mq [just a bystander]